11.150
−3,04%
2026-10-19
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +13.7% | +13.3% | 3 / 3 | -9.4% | +6.38 pp | +1.42 pp | +10.4% | 0.15 | 6.24 | 104 | −9,4% | 7,3 | +13,7% | 6.24 | 7.35 | −15,1% |
| Pts | 0 | 0 | 12 | 0 | 12 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 11.150 (close price on 2026-10-19)EPS (TTM): 1.787
Financial charts
1.Revenue & growth
VND bn102Q2/26
1.Revenue & growth
VND bn102Q2/26
2.Profit & growth
VND bn7,30Q2/26
3.Profit mix (Penman)
VND bn27,8Q2/26
4.Margins & cost structure
%17.8%Q2/26
5.Returns & cash cycle
% · days10.0%Q2/26
6.Earnings quality & cash
VND bn14,7Q2/26
7.Asset structure
VND bn303Q2/26
8.Funding & debt health
VND bn · times303Q2/26
9.Revenue backlog
VND bn4,77Q2/26
10.Valuation
times · %6,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %590Q2/26
Adjusted EPS growth, latest quarter
14.1%
Average adjusted EPS growth, 3 quarters
13.4%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26